Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Luc Dirix, Erika Hamilton, Guy Jérusalem et al.|Breast Cancer Research and Treatment|2017

Cited by 761